Abstract The BAM15 / SLU-PP-332 tablet formulation represents a cutting-edge “Exercise Mimetic” research blend. It combines BAM15 (N5,N6-bis(2-fluorophenyl)-[1,2,5]oxadiazolo[3,4-b]pyrazine-5,6-diamine), a highly selective mitochondrial protonophore uncoupler, with SLU-PP-332, a potent Estrogen-Related Receptor Alpha (ERR$\alpha$) agonist. This dual-action approach targets metabolic regulation from two distinct angles: BAM15 physically uncouples oxidative phosphorylation to burn calories as heat (thermogenesis) without altering ATP production in non-target tissues, while SLU-PP-332 transcriptionally reprogrammes skeletal muscle towards an oxidative, endurance-like phenotype. This blend is the premier reagent for investigating the “coupling” of increased energy expenditure with enhanced fatty acid oxidation in models of obesity, metabolic syndrome, and muscle atrophy.

Mechanism and Research Interest

Primary Biological Pathway: Mitochondrial Uncoupling (BAM15) BAM15 is a second-generation mitochondrial uncoupler. Unlike historical agents like DNP (2,4-Dinitrophenol) which are toxic due to non-selective plasma membrane depolarization, BAM15 is restricted to the mitochondrial inner membrane. It transports protons (H+) from the intermembrane space back into the matrix, bypassing ATP Synthase. This “short-circuit” forces the mitochondria to consume more oxygen and fuel (fatty acids/glucose) to maintain the proton gradient, dissipating the excess energy as heat. Research utilises this compound to model Safe Thermogenesis, investigating its ability to reduce adiposity and improve insulin sensitivity without the risk of fatal hyperthermia.

Secondary Biological Pathway: ERR$\alpha$ Agonism (SLU-PP-332) SLU-PP-332 mimics the transcriptional effects of endurance exercise. It binds to the Estrogen-Related Receptor Alpha (ERR$\alpha$), a nuclear receptor that regulates mitochondrial biogenesis and oxidative metabolism genes. Administration of SLU-PP-332 has been shown to increase Type IIa (oxidative) muscle fibers and enhance running endurance in sedentary mice. In this blend, it serves to “train” the muscle metabolically, ensuring that the fuel liberated by BAM15 is efficiently oxidised rather than re-esterified.

Synergistic Research Finding: The “Calorie Burn + Remodelling” Effect The combination of BAM15 and SLU-PP-332 addresses the two pillars of weight loss: Energy Expenditure (BAM15) and Metabolic Efficiency (SLU-PP-332). While BAM15 burns the fuel, SLU-PP-332 upregulates the machinery (Cpt1b, Pgc1$\alpha$) required to process fatty acids. Research utilising this blend investigates whether the combination prevents the muscle wasting often seen with rapid weight loss, promoting a “lean and fit” phenotype even in the absence of physical activity.

Long-term Genomic and Safety Observations Safety pharmacology focuses on Kidney and Liver Function. Since BAM15 is cleared rapidly and SLU-PP-332 alters systemic metabolism, longitudinal studies monitor markers of toxicity (ALT/AST, Creatinine). Additionally, core body temperature is strictly monitored to verify that the uncoupling effect of BAM15 remains within the therapeutic window and does not override thermoregulatory control centers.

Product Specifications

• Purity: Each component is validated at >98+% via High-Performance Liquid Chromatography (HPLC) prior to tablet compression. We ensure the absence of heavy metal catalysts often used in the synthesis of oxadiazole rings (BAM15).

• Appearance: The tablets are uniform, typically off-white to pale yellow, designed for oral administration in larger animal models or for crushing/suspension in feed for rodent studies.

• Bioavailability: Both compounds are orally active. BAM15 has poor water solubility but high lipid permeability; SLU-PP-332 is optimised for metabolic stability. The tablet matrix aids in the disintegration and dissolution required for intestinal absorption.

• Storage: The product must be stored at room temperature (20∘C to 25∘C), protected from light and moisture.

Storage and Handling Guidelines

Stability and Shelf Life The BAM15 / SLU-PP-332 Tablets are stable in their solid dose form. The shelf life is 24 months when stored properly in the sealed container. Researchers should keep the bottle tightly closed to prevent moisture uptake, which can degrade the tablet excipients.

Oral Administration in Research For rodent studies, tablets are often crushed and suspended in a vehicle (e.g., methylcellulose) or incorporated into a high-fat diet. Dosages must be carefully calculated based on mg/kg body weight.

• BAM15 typical range: 5mg/kg – 50mg/kg daily.

• SLU-PP-332 typical range: 10mg/kg – 25mg/kg daily.

• Note: Researchers must validate the specific ratio within the tablet for their protocol.

Safety Warning Thermogenic Hazard. While BAM15 is safer than DNP, high doses of any mitochondrial uncoupler can elevate body temperature. Researchers must monitor rectal temperature in animal models, especially during the induction phase. Avoid administering in environments with high ambient temperatures (>30°C) as this compromises the animal’s ability to dissipate the heat generated by uncoupling.

Why Choose the BAM15 / SLU-PP-332 Blend?

This blend is the definitive tool for Sedentary Metabolic Research. Physical exercise is the gold standard for health, but many disease states (paralysis, severe obesity, frailty) preclude it. This “Exercise in a Pill” concept allows researchers to bypass the mechanical requirement of exercise and directly activate the metabolic benefits.

It provides a sophisticated dual-mechanism approach:

1. Immediate Caloric Deficit (via BAM15 uncoupling).

2. Sustained Metabolic Reprogramming (via SLU-PP-332 gene activation).

For researchers investigating related metabolic pathways, we recommend examining:

• MOTS-c 10mg: (A mitochondrial-derived peptide that also acts as an exercise mimetic).

• 5-Amino-1MQ: (For inhibition of NNMT and enhancement of NAD+ flux in adipose tissue).

• Cardarine (GW-501516): (For PPAR$\delta$ agonism and fatty acid oxidation research).

Disclaimer

This product is strictly for Research Use Only (RUO). It is not intended for human consumption (e.g., as a diet pill, bodybuilding supplement, or exercise replacement), therapeutic use, or diagnostic procedures. The information provided is for educational and scientific reference only. Purchase is restricted to verified research institutions and qualified individuals. Any evidence of intended misuse for human application will result in immediate order cancellation and blacklisting, in compliance with UK research chemical regulations.